Suppr超能文献

传统的体外受精在患有和不患有子宫内膜异位症的女性中的效果相似。

Conventional IVF performs similarly in women with and without endometriosis.

机构信息

Infertility Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via F. Sforza 28, 20122, Milan, Italy.

Division of Human Reproduction, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

出版信息

J Assist Reprod Genet. 2023 Mar;40(3):599-607. doi: 10.1007/s10815-022-02700-z. Epub 2023 Jan 13.

Abstract

PURPOSE

A reduced oocyte competence has been claimed as one of the factors underlying infertility in women with endometriosis. This idea has justified the hypothesis that intracytoplasmic sperm injection (ICSI), rather than conventional IVF (c-IVF), may overcome oocyte impairment and ensure better assisted reproduction technology (ART) outcomes; however, data from the literature are controversial. Thus, the aim of this study was to compare ART success rates following (c-IVF) between women with and without endometriosis in the presence of normozoospermic partners.

METHODS

This is a retrospective, matched case-control study of 314 patients who underwent c-IVF cycles between January 2014 and December 2020. Women with endometriosis were matched in a 1:1 ratio with patients undergoing ART for other indications, considering age (± 6 months), number of oocytes retrieved (± 1), and study period. The main outcome measures included total fertilization failure, fertilization rate, embryo quality, cumulative clinical pregnancy, and live birth rates.

RESULTS

The fertilization rate and the proportion of women with total fertilization failure did not differ between women with and without endometriosis. Similarly, all other embryological variables did not also differ, except for the number of top-quality cleavage stage embryos which was higher in the endometriosis group. Cumulative clinical pregnancy and live birth rates were similar between women with and without endometriosis.

CONCLUSION

A diagnosis of endometriosis does not negatively affect the performance of c-IVF; thus, c-IVF can be efficiently used in women affected, unless a male factor is also involved. This issue holds clinical relevance to help operators on their insemination technique decision-making.

摘要

目的

有人认为,卵母细胞功能降低是子宫内膜异位症女性不孕的原因之一。这一观点使人们假设,胞浆内单精子注射(ICSI)而非常规体外受精(c-IVF)可能克服卵母细胞损伤,确保更好的辅助生殖技术(ART)结局;然而,文献中的数据存在争议。因此,本研究旨在比较有和无子宫内膜异位症的正常精子伴侣的患者接受 c-IVF 后的 ART 成功率。

方法

这是一项回顾性、1:1 配对病例对照研究,纳入了 314 名于 2014 年 1 月至 2020 年 12 月期间接受 c-IVF 周期的患者。根据年龄(±6 个月)、获卵数(±1)和研究期间,将患有子宫内膜异位症的患者与接受 ART 治疗其他适应症的患者进行 1:1 配对。主要结局指标包括总受精失败率、受精率、胚胎质量、累积临床妊娠率和活产率。

结果

子宫内膜异位症患者与无子宫内膜异位症患者的受精率和总受精失败率无差异。同样,除优质卵裂期胚胎数量较高外,所有其他胚胎学变量也无差异。子宫内膜异位症患者和无子宫内膜异位症患者的累积临床妊娠率和活产率相似。

结论

子宫内膜异位症的诊断不会对 c-IVF 的表现产生负面影响;因此,除非还存在男性因素,否则可以有效地在受影响的女性中使用 c-IVF。这个问题对帮助操作人员做出授精技术决策具有临床意义。

相似文献

1
Conventional IVF performs similarly in women with and without endometriosis.
J Assist Reprod Genet. 2023 Mar;40(3):599-607. doi: 10.1007/s10815-022-02700-z. Epub 2023 Jan 13.
2
Analysis of IVF/ICSI-FET Outcomes in Women With Advanced Endometriosis: Influence on Ovarian Response and Oocyte Competence.
Front Endocrinol (Lausanne). 2020 Jul 17;11:427. doi: 10.3389/fendo.2020.00427. eCollection 2020.
3
The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
Hum Reprod. 2017 Jan;32(1):119-124. doi: 10.1093/humrep/dew298. Epub 2016 Nov 16.
5
ICSI does not increase the cumulative live birth rate in non-male factor infertility.
Hum Reprod. 2018 Jul 1;33(7):1322-1330. doi: 10.1093/humrep/dey118.
6
In vitro fertilization and multiple pregnancies: an evidence-based analysis.
Ont Health Technol Assess Ser. 2006;6(18):1-63. Epub 2006 Oct 1.
8
Impact of moderate-to-severe endometriosis on IVF cumulative live birth rate: a retrospective matched cohort study.
Reprod Biomed Online. 2023 Sep;47(3):103186. doi: 10.1016/j.rbmo.2023.02.012. Epub 2023 Mar 4.
9
Conventional IVF versus ICSI in sibling oocytes from couples with endometriosis and normozoospermic semen.
J Assist Reprod Genet. 2013 Feb;30(2):251-7. doi: 10.1007/s10815-012-9922-8. Epub 2012 Dec 28.

引用本文的文献

1
The Effects of Endometriosis on Oocyte and Embryo Quality.
J Clin Med. 2025 Mar 28;14(7):2339. doi: 10.3390/jcm14072339.
2
Comparison of success rates in early stages of in vitro fertilization (IVF) in women with and without endometriosis.
Narra J. 2024 Dec;4(3):e1019. doi: 10.52225/narra.v4i3.1019. Epub 2024 Sep 23.
3
What is the impact of endometriosis and the AFS stage on cumulative pregnancy rates in IVF programs?
Reprod Health. 2024 Jan 29;21(1):13. doi: 10.1186/s12978-024-01747-8.
4
Nonsurgical approaches to the diagnosis and evaluation of endometriosis.
Fertil Steril. 2024 Feb;121(2):140-144. doi: 10.1016/j.fertnstert.2023.12.020. Epub 2023 Dec 15.
5
Endometriosis and IVF treatment outcomes: unpacking the process.
Reprod Biol Endocrinol. 2023 Nov 7;21(1):107. doi: 10.1186/s12958-023-01157-8.

本文引用的文献

1
Opportunities and Limits of Conventional IVF versus ICSI: It Is Time to Come off the Fence.
J Clin Med. 2022 Sep 27;11(19):5722. doi: 10.3390/jcm11195722.
2
The impact of endometriosis on IVF efficacy: qualitative and quantitative assessment of ovarian response and embryo development.
Reprod Biomed Online. 2022 Aug;45(2):275-281. doi: 10.1016/j.rbmo.2022.04.010. Epub 2022 Apr 27.
3
ESHRE guideline: endometriosis.
Hum Reprod Open. 2022 Feb 26;2022(2):hoac009. doi: 10.1093/hropen/hoac009. eCollection 2022.
5
Does Ovarian Endometriosis Increase Oocyte Sensitivity to ICSI-Induced Mechanical Damage?
J Clin Med. 2021 Apr 18;10(8):1757. doi: 10.3390/jcm10081757.
8
Endometriosis is a chronic systemic disease: clinical challenges and novel innovations.
Lancet. 2021 Feb 27;397(10276):839-852. doi: 10.1016/S0140-6736(21)00389-5.
9
Management of endometriosis-related infertility: Considerations and treatment options.
Clin Exp Reprod Med. 2020 Mar;47(1):1-11. doi: 10.5653/cerm.2019.02971. Epub 2020 Feb 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验